Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Delve into why combining bond ladder with index funds can deliver smoother cash flow and improved diversification.
22,610 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A prototype AI agent reportedly moved an entire Lobstar token stake to a social-media reply target, booked quick prof...
Keysight Technologies surged to an all-time high after posting a stronger-than-expected Q1 FY2026, driven by AI infra...
First Trust AIRR, a small-cap industrial-focused ETF, has surged in 2026 and boasts a five-year performance well ahea...
DTCC’s real-world asset push is reshaping the institutional crypto stack. On one side lies Canton Network’s private-r...
A high-stakes moment at Davos shifted sentiment in crypto markets. Michael Saylor announced a record BTC purchase, wh...
A new AI-based forecast suggests XRP, SOL and SHIB could see significant upside by the end of 2026, even as traders w...
Canaccord Genuity lowers AeroVironment's target to $330 but preserves a Buy rating, underscoring long-term optimism a...
A new look at the equipment carried by WWII paratroopers sheds light on how historical burdens shape modern defense b...
A supply-driven oil shock could force the Fed to put off rate cuts, creating a liquidity squeeze that analysts say co...
Global markets tumble as crude crosses the $100 mark, triggering a broad risk-off move and rising household costs. He...
Google’s Gemini AI projects bold price paths for XRP, Solana, and Cardano by year-end 2026, stressing funding momentu...